Back to News
Market Impact: 0.5

L3Harris Technologies Q4 Net Income Declines

LHX
Corporate EarningsCorporate Guidance & OutlookCompany FundamentalsInfrastructure & DefenseManagement & GovernanceTechnology & InnovationInvestor Sentiment & Positioning
L3Harris Technologies Q4 Net Income Declines

L3Harris reported Q4 net income attributable to the company of $300 million versus $453 million a year ago, with GAAP EPS of $1.59 (prior $2.37) while non-GAAP EPS rose to $2.86 from $2.60 and pension-adjusted non-GAAP EPS increased to $2.32 from $2.17. Revenue was $5.6 billion, up 2% year-over-year (6% organically), and management cited a record backlog and ongoing investments in technology, capex and R&D. For FY2026 the company guided to EPS of $11.30–$11.50 and revenue of $23.0B–$23.5B; shares traded down ~4.3% pre-market on the release. Investors should weigh weaker GAAP profitability against stronger non-GAAP metrics and the upbeat guidance/backlog when assessing positioning.

Analysis

Market structure: LHX’s mixed Q4 (GAAP miss, non‑GAAP beat, organic rev +6%) and strong 2026 guidance (EPS $11.30–$11.50, rev $23–23.5B) favors prime contractors with exposed tech/capacity investments and their specialized suppliers (RF/microwave semiconductors, avionics OEMs). Short-term investor pain (shares -4.3% premarket) reflects earnings haircut rather than demand collapse — backlog described as “record” implies multi‑quarter revenue visibility and improved pricing power on scarce high‑end systems. Cross‑asset: a sustained bid in defense equities would tighten credit spreads for rated primes, lower idiosyncratic equity vols; FX/commodities impact minimal but industrial metals/semiconductor supply chains could see order tailwinds. Risk assessment: tail risks include program cost overruns, major contract protests/cancellations, export-control work stoppages, or a material supply‑chain semiconductor squeeze that compresses margins; any of these could erase the guidance premium. Immediate (days): sentiment-driven volatility; short-term (weeks–months): backlog conversion and Q1 guidance cadence; long-term (quarters–years): capex+R&D investments should convert to higher margin products if execution stays on plan. Hidden dependencies: margin recovery depends on conversion of classified/high‑mix programs and subcontractor capacity, not just topline; watch FCF vs. elevated capex. Trade implications: tactically favor LHX exposure vs. peers if you believe management can convert backlog — consider a 2–3% long position in LHX executed on dips to $320–$330 with a 12‑month horizon. Relative-value: pair long LHX, short RTX (RTX) 1:0.8 notional for 6–12 months to isolate defense demand vs. company execution. Options: buy 9–12 month calls ~6–10% OTM (allocate 0.5–1% portfolio) or put on a protective 6‑month 10% OTM put if initiating cash long. Rotate modestly into Aerospace & Defense (XAR or XLU? — use A&D ETFs) and away from interest‑rate sensitive industrials if macro softens. Contrarian angle: consensus is punishing LHX for a GAAP EPS drop while non‑GAAP metrics and strong FY26 guide indicate operational momentum — the selloff looks overdone by ~5–8% relative to peers given backlog visibility. Historical parallels: post‑guide selloffs in primes have reversed within 3–9 months when backlog conversion met targets; if LHX posts two consecutive quarters of beat-and-raise, upside could be +20–30% from current levels. Unintended consequence: if investors push for immediate cash returns, elevated capex could be curtailed, slowing long‑term margin expansion — prefer conviction-sized but measured exposure until conversion confirms.